ESRRG and neoplasm: Tumor Immune Dysfunction and Exclusion (TIDE) scores indicate sensitivity to immune checkpoint inhibitors; therefore, we evaluated differences in TIDE scores between the ESRRG high expression and low expression groups in the TCGA-ESCC dataset.